S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
GE   12.61 (-1.10%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
GE   12.61 (-1.10%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
GE   12.61 (-1.10%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
GE   12.61 (-1.10%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

NYSEAMERICAN:PTN - Palatin Technologies Stock Price, Forecast & News

$0.58
-0.01 (-1.69 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
$0.58
Now: $0.58
$0.60
50-Day Range
$0.87
MA: $0.93
$1.06
52-Week Range
$0.58
Now: $0.58
$1.78
Volume1.23 million shs
Average Volume1.29 million shs
Market Capitalization$132.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted, receptor-specific therapeutics for the treatment of various diseases in the United States. The company's principal product is Vyleesi, an on demand subcutaneous injectable product that has completed Phase III clinical studies for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:PTN
CUSIPN/A
Phone+1-609-4952200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees19
Market Cap$132.96 million
Next Earnings Date5/14/2020 (Estimated)
OptionableNot Optionable

Receive PTN News and Ratings via Email

Sign-up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter.


Palatin Technologies (NYSEAMERICAN:PTN) Frequently Asked Questions

What is Palatin Technologies' stock symbol?

Palatin Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "PTN."

How were Palatin Technologies' earnings last quarter?

Palatin Technologies, Inc. (NYSEAMERICAN:PTN) released its quarterly earnings results on Tuesday, February, 11th. The biopharmaceutical company reported ($0.02) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.01) by $0.01. The biopharmaceutical company had revenue of $0.02 million for the quarter, compared to the consensus estimate of $4.48 million. During the same period in the previous year, the business earned ($0.02) EPS. View Palatin Technologies' Earnings History.

When is Palatin Technologies' next earnings date?

Palatin Technologies is scheduled to release their next quarterly earnings announcement on Thursday, May 14th 2020. View Earnings Estimates for Palatin Technologies.

What price target have analysts set for PTN?

3 analysts have issued 12-month price objectives for Palatin Technologies' shares. Their forecasts range from $2.00 to $6.00. On average, they anticipate Palatin Technologies' share price to reach $3.67 in the next twelve months. This suggests a possible upside of 532.2% from the stock's current price. View Analyst Price Targets for Palatin Technologies.

What is the consensus analysts' recommendation for Palatin Technologies?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Palatin Technologies in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Palatin Technologies.

Has Palatin Technologies been receiving favorable news coverage?

News headlines about PTN stock have trended neutral on Wednesday, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Palatin Technologies earned a news impact score of 0.1 on InfoTrie's scale. They also assigned media coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Palatin Technologies.

Who are some of Palatin Technologies' key competitors?

What other stocks do shareholders of Palatin Technologies own?

Who are Palatin Technologies' key executives?

Palatin Technologies' management team includes the folowing people:
  • Dr. John K. A. Prendergast, Co-Founder & Non-Exec. Chairman (Age 65)
  • Dr. Carl Spana, Co-Founder, Pres, CEO & Director (Age 57)
  • Mr. Stephen T. Wills CPA, CPA, MST, CFO, COO, Exec. VP, Treasurer & Sec. (Age 62)
  • Burns McClellan, VP of Investor Relations

Who are Palatin Technologies' major shareholders?

Palatin Technologies' stock is owned by many different of retail and institutional investors. Top institutional investors include State Street Corp (1.55%), Acadian Asset Management LLC (1.42%), Strs Ohio (0.34%), AQR Capital Management LLC (0.32%), Bank of New York Mellon Corp (0.24%) and Charles Schwab Investment Management Inc. (0.24%). Company insiders that own Palatin Technologies stock include Alan W Dunton, Arlene Morris, Carl Spana, Joseph Stanley Hull, Robert K Deveer Jr and Stephen T Wills. View Institutional Ownership Trends for Palatin Technologies.

Which institutional investors are selling Palatin Technologies stock?

PTN stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, New York State Common Retirement Fund, Oxford Asset Management LLP and California Public Employees Retirement System. View Insider Buying and Selling for Palatin Technologies.

Which institutional investors are buying Palatin Technologies stock?

PTN stock was bought by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Acadian Asset Management LLC, Virtu Financial LLC, Strs Ohio, Banque Cantonale Vaudoise, Barclays PLC, UBS Group AG and State Street Corp. Company insiders that have bought Palatin Technologies stock in the last two years include Alan W Dunton, Arlene Morris, Carl Spana, Joseph Stanley Hull, Robert K Deveer Jr and Stephen T Wills. View Insider Buying and Selling for Palatin Technologies.

How do I buy shares of Palatin Technologies?

Shares of PTN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Palatin Technologies' stock price today?

One share of PTN stock can currently be purchased for approximately $0.58.

How big of a company is Palatin Technologies?

Palatin Technologies has a market capitalization of $132.96 million. Palatin Technologies employs 19 workers across the globe.View Additional Information About Palatin Technologies.

What is Palatin Technologies' official website?

The official website for Palatin Technologies is http://www.palatin.com/.

How can I contact Palatin Technologies?

Palatin Technologies' mailing address is 4B Cedarbrook Dr, CRANBURY, NJ 08512-3641, United States. The biopharmaceutical company can be reached via phone at +1-609-4952200.


MarketBeat Community Rating for Palatin Technologies (NYSEAMERICAN PTN)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  409 (Vote Outperform)
Underperform Votes:  284 (Vote Underperform)
Total Votes:  693
MarketBeat's community ratings are surveys of what our community members think about Palatin Technologies and other stocks. Vote "Outperform" if you believe PTN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PTN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel